Variant Creutzfeldt-Jakob disease, a cause for concern - Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery

被引:4
|
作者
Olsen, SB [1 ]
Sheikh, A
Peck, D
Darzi, A
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg Technol & Oncol, St Marys Hosp, London W2 1NY, England
[2] Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2005年 / 19卷 / 06期
关键词
v-CJD; surgery; prions; transmission; lymphoreticular;
D O I
10.1007/s00464-004-9205-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Concerti has long existed regarding the possible iatrogenic spread of variant Creutzfeldt-Jakob disease (v-CJD) through surgery. This had been fueled by recent reports of bovine spongiform encephalopathy in U.S. cattle and the first probable case of blood transmission of v-CJD in the UK. Methods: Systematic review of experimental and non-experimental Studies. Studies identified from searches of Medline. Embase. Cochrane Library. Science Citation Index medical databases, searching bibliographies of retrieved papers, and personal communication with international experts in the field. Results: Six articles satisfied our search criteria. Evidence stems from case reports, case series, and cross-sectional Studies. There are no published cases of surgically transmitted v-CJD. Conclusion: We found evidence of v-CJD prion agents in the spleen, appendix. rectum, and adrenal glands of affected patients and evidence of v-CJD priori in the appendix of patients in the preclinical stage of the disease. The risk of transmission of v-CJD prion during abdominal surgery is Currently unquantifiable.
引用
收藏
页码:747 / 750
页数:4
相关论文
共 41 条
  • [21] Investigation of Variant Creutzfeldt-Jakob Disease Implicated Organ or Tissue Transplantation in the United Kingdom
    Molesworth, Anna
    Yates, Philip
    Hewitt, Patricia E.
    Mackenzie, Jan
    Ironside, James W.
    Galea, George
    Ward, Hester J. T.
    TRANSPLANTATION, 2014, 98 (05) : 585 - 589
  • [22] Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks
    di Borgo, Alexis Pozzo
    Rochette, Samuel
    Gaussen, Amaury
    O'Brien, Sheila F.
    Germain, Marc
    Renaud, Christian
    Lewin, Antoine
    TRANSFUSION MEDICINE REVIEWS, 2023, 37 (03)
  • [23] Assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease: a European perspective
    Domanovic, Dragoslav
    Lewin, Antoine
    O'Leary, Peter
    Janner-Jametti, Tiziana
    El Dusouqui, Soraya Amar
    Sousa, Ana Paula
    Zaaije, Hans
    Roberts, Barnaby
    Bougard, Daisy
    Prati, Daniele
    Nordberg, Jonas
    Erikstrup, Christian
    Janssen, Mart
    Lieshout-Krikke, Ryanne
    Gubbe, Knut
    O'Flaherty, Niamh
    Mathy, Genevieve
    Chantillon, Andree-Marie
    Lehtisalo, Riikka
    Sorensen, Ofsteng H.
    Tiberghien, Pierre
    Thomas, Stephen
    BLOOD TRANSFUSION, 2024, 22 (05)
  • [24] Assessment of risk of variant creutzfeldt-Jakob disease (vCJD) from use of bovine heparin
    Huang Yin
    Forshee, Richard A.
    Keire, David
    Lee, Sau
    Gregori, Luisa
    Asher, David M.
    Bett, Cyrus
    Niland, Brian
    Brubaker, Scott A.
    Anderson, Steven A.
    Yang Hong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (05) : 575 - 581
  • [25] Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt-Jakob disease: The SaBTO review
    Thomas, Stephen
    Katz, Matthew
    Slowther, Anne-Marie
    Coelho, Emily
    Mallinson, Gary
    TRANSFUSION MEDICINE, 2022, 32 (01) : 24 - 31
  • [26] Removal of deferrals for variant Creutzfeldt-Jakob disease risk: Impact on new and previously deferred donors
    Goldman, Mindy
    Mckee, David
    Smith, Shane
    O'Brien, Sheila F.
    VOX SANGUINIS, 2025,
  • [27] Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment
    Sachse, C
    Groschup, MH
    Warzok, R
    Greinacher, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (01) : 11 - 16
  • [28] Universal White Blood Cell Reduction in Europe: Has Transmission of Variant Creutzfeldt-Jakob Disease Been Prevented?
    Vamvakas, Eleftherios C.
    TRANSFUSION MEDICINE REVIEWS, 2011, 25 (02) : 133 - 144
  • [29] Bioassay Studies Support the Potential for Iatrogenic Transmission of Variant Creutzfeldt Jakob Disease through Dental Procedures
    Kirby, Elizabeth
    Dickinson, Joanne
    Vassey, Matthew
    Dennis, Mike
    Cornwall, Mark
    McLeod, Neil
    Smith, Andrew
    Marsh, Philip D.
    Walker, James T.
    Sutton, J. Mark
    Raven, Neil D. H.
    PLOS ONE, 2012, 7 (11):
  • [30] The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products
    Zaman, S. M. A.
    Hill, F. G. H.
    Palmer, B.
    Millar, C. M.
    Bone, A.
    Molesworth, A. M.
    Connor, N.
    Lee, C. A.
    Dolan, G.
    Wilde, J. T.
    Gill, O. N.
    Makris, M.
    HAEMOPHILIA, 2011, 17 (06) : 931 - 937